Sj. Wright et Mj. Keating, CYCLOSPORINE-A IN CHRONIC LYMPHOCYTIC-LEUKEMIA - DUAL ANTILEUKEMIC AND IMMUNOSUPPRESSIVE ROLE, Leukemia & lymphoma, 20(1-2), 1995, pp. 131-136
The association of hemolytic anemia and other autoimmune cytopenias wi
th chronic lymphocytic leukemia (CLL) is well known. The etiology of t
hese immune syndromes is still uncertain, despite evidence that the pu
tative cell of origin of the B-CLL cell produces naturally occurring a
utoantibodies. Cyclosporine A is effective in treating the immune mani
festations associated with CLL and, occasionally, has shown anti-leuke
mic activity. We report two cases in which cyclosporine A treatment of
autoimmune hemolytic anemia resulted in reduction of CLL cell burden.
We then discuss the possible mechanism of action of cyclosporine A an
d the nature of the autoimmune processes involved.